RTI Surgical Inc (RTIX) Expected to Post Quarterly Sales of $70.16 Million

Analysts expect RTI Surgical Inc (NASDAQ:RTIX) to post $70.16 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for RTI Surgical’s earnings. The lowest sales estimate is $69.49 million and the highest is $70.82 million. RTI Surgical posted sales of $71.35 million during the same quarter last year, which would indicate a negative year over year growth rate of 1.7%. The business is expected to announce its next earnings results on Thursday, February 22nd.

On average, analysts expect that RTI Surgical will report full-year sales of $70.16 million for the current fiscal year, with estimates ranging from $278.40 million to $279.56 million. For the next year, analysts expect that the firm will post sales of $282.10 million per share, with estimates ranging from $281.94 million to $282.26 million. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side analysts that follow RTI Surgical.

RTI Surgical (NASDAQ:RTIX) last announced its earnings results on Thursday, November 2nd. The medical equipment provider reported $0.01 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.01. RTI Surgical had a net margin of 1.01% and a return on equity of 2.29%. The company had revenue of $66.69 million for the quarter, compared to analysts’ expectations of $65.63 million. The firm’s quarterly revenue was up .2% compared to the same quarter last year.

Several analysts recently issued reports on RTIX shares. Zacks Investment Research lowered shares of RTI Surgical from a “hold” rating to a “sell” rating in a research report on Thursday, October 5th. BidaskClub upgraded shares of RTI Surgical from a “strong sell” rating to a “sell” rating in a research report on Saturday, January 6th.

Shares of RTI Surgical (NASDAQ RTIX) opened at $4.45 on Friday. The company has a current ratio of 3.34, a quick ratio of 1.21 and a debt-to-equity ratio of 0.25. The stock has a market cap of $270.70, a P/E ratio of -63.57, a P/E/G ratio of 1.98 and a beta of 1.76. RTI Surgical has a 52-week low of $3.01 and a 52-week high of $6.00.

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Victory Capital Management Inc. boosted its position in shares of RTI Surgical by 23.4% during the 4th quarter. Victory Capital Management Inc. now owns 254,576 shares of the medical equipment provider’s stock worth $1,044,000 after acquiring an additional 48,242 shares in the last quarter. Algert Global LLC boosted its position in shares of RTI Surgical by 8.8% during the 4th quarter. Algert Global LLC now owns 204,901 shares of the medical equipment provider’s stock worth $840,000 after acquiring an additional 16,500 shares in the last quarter. Wedge Capital Management L L P NC boosted its position in shares of RTI Surgical by 33.5% during the 4th quarter. Wedge Capital Management L L P NC now owns 335,700 shares of the medical equipment provider’s stock worth $1,376,000 after acquiring an additional 84,200 shares in the last quarter. Foundry Partners LLC boosted its position in shares of RTI Surgical by 35.8% during the 4th quarter. Foundry Partners LLC now owns 1,107,745 shares of the medical equipment provider’s stock worth $4,542,000 after acquiring an additional 292,320 shares in the last quarter. Finally, SG Americas Securities LLC acquired a new stake in shares of RTI Surgical during the 4th quarter worth approximately $113,000. Institutional investors and hedge funds own 69.94% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This article was first posted by American Banking News and is owned by of American Banking News. If you are accessing this article on another website, it was illegally stolen and reposted in violation of United States and international copyright and trademark law. The correct version of this article can be accessed at https://www.americanbankingnews.com/2018/02/02/rti-surgical-inc-rtix-expected-to-post-quarterly-sales-of-70-16-million-3.html.

About RTI Surgical

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Get a free copy of the Zacks research report on RTI Surgical (RTIX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply